John Sinkins, CFAMedimmuneMEDITOP PICKDec 08, 2003

Has a flu virus vaccine and they expect sales will pick up. They have other respiratory products which continue to do well.

John Sinkins, CFA

Owned

Unlock Rating

$27.85

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Their flu vaccine looks promising. A lot of cash flow. Trading at 20 X next years earnings.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

John Sinkins, CFAMedimmuneMEDITOP PICKDec 08, 2003

You might be interested:

Medimmune(MEDI)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals